Latest News
Pfizer Gains FDA Nod for Padcev Combo, Yet Stock Remains Flat
Pfizer's Padcev/Keytruda combo gets FDA approval for bladder cancer, but the stock dipped 0.33%. Wall Street remains cautious about revenue impact.
Verizon's 6.7% Yield: The Rate Factor That Will Determine Next Move
Verizon's 6.72% yield cushions price falls but can't close the performance gap with peers. The stock's next move depends on Tuesday's CPI report and Treasury yields.
June CPI Data Set to Test Wall Street's Fragile Optimism
The June CPI report, Fed testimony, and bank earnings will test the S&P 500's rally. Lower gas prices may ease headline inflation, but core inflation and service costs remain sticky.
USPS Forever Stamp Hits 82 Cents; Rate Formula Signals Further Increases
The U.S. Postal Service raised the Forever stamp to 82 cents, and the rate-setting formula suggests more increases ahead as mail volume continues to drop.
Space Stocks Struggle Despite SpaceX's Nasdaq-100 Debut
SpaceX's inclusion in the Nasdaq-100 hasn't reversed the selloff in space stocks, with peers like Rocket Lab and Planet Labs declining sharply despite technical milestones.
Healthcare Earnings Test: J&J, UnitedHealth, Abbott in Focus After Sector's 9% Drop
Major healthcare stocks report this week as the sector's 9% earnings decline goes under the microscope. J&J, UnitedHealth, and Abbott are key to determining if the drop is real or just a one-off.





